Skip to content

IMDX IMDX Price / sales

Price / sales at other companies

CareDx logo
CareDxCDNA
2.2×-0.7×
Guardant Health logo
Guardant HealthGH
11.2×+4.4×
Natera, Inc. logo
Natera, Inc.NTRA
11.3×+0.9×
Fulgent Genetics, Inc. logo
Fulgent Genetics, Inc.FLGT
1.6×-0.2×
Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
2.9×+0.2×
Agilent Technologies logo
Agilent TechnologiesA
4.5×-0.1×

Other financials

Income statement

See full
Revenue$32.0K-98.5%
Gross profit$15.0K-98.9%
Operating income-$4.4M+35.1%
Net income-$4.3M+35.7%
EPS (diluted)-$0.12+53.8%

Balance sheet

See full
Cash & equivalents$28.2M-9.1%
Total debt$2.9M-13.5%
Total equity-$10.7M-205%
Total assets$40.4M-33.0%

Cash flow

See full
Operating cash flow-$7.6M-30.8%
CapEx$613.0K+99.7%
Free cash flow-$8.3M-34.3%

Valuation

See full
Market cap$185.35M+92.3%
Enterprise value$160.03M+113%

Profitability

See full
Gross margin51.3%-3.0pp
Operating margin-2,500.7%+4,459pp
Net margin-2,454.6%+4,017pp
FCF margin-1,409.7%-6,023pp

Returns & leverage

See full
Return on equity-532.9%-717pp
Debt / equity2.9×+2.8×
Current ratio2.5×-1.2×

Where this comes from

Calculated from IMDX’s reported figures.

Based on the most recent quarter.

The official record: IMDX’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about IMDX's price / sales.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is IMDX's price / sales?
IMDX (IMDX) reported price / sales of 54.1× in Q1 2026.
What does price / sales mean?
Market capitalization at the quarter end divided by trailing-twelve-month revenue. The price the market pays for each dollar of sales.